ID: ALA325653

Max Phase: Preclinical

Molecular Formula: C6H13N5

Molecular Weight: 155.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1C(N)=NC(N)=NC1(C)C

Standard InChI:  InChI=1S/C6H13N5/c1-6(2)10-4(7)9-5(8)11(6)3/h1-3H3,(H4,7,8,9,10)

Standard InChI Key:  GEUHWGYMTDPIEL-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydrofolate reductase type 1 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 155.21Molecular Weight (Monoisotopic): 155.1171AlogP: -0.70#Rotatable Bonds: 0
Polar Surface Area: 80.00Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.38CX LogP: -0.72CX LogD: -2.78
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.49Np Likeness Score: 0.32

References

1. Ghose AK, Crippen GM..  (1985)  Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.,  28  (3): [PMID:3882967] [10.1021/jm00381a013]

Source